Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (581-590 of 664) with videos related to

Pageof 67
Sort By:
Neuro-Oncology|April 18, 2001
Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption ConsortiumN D Doolittle, C P Anderson, W A Bleyer, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Life Science Alliance|January 22, 2022
Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for reninMark Sicking, Martina Živná, Pratiti Bhadra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Conduct of phase I trials in children with cancerM Smith, M Bernstein, W A Bleyer, et al.
Human Molecular Genetics|October 11, 2019
PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcomeAnna Pelet, Vaclava Skopova, Ulrike Steuerwald, et al.
Plos One|May 5, 2020
Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failureSebastian Clauss, Dominik Schüttler, Christina Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Journal of Virology|June 20, 2024
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate modelChristiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Vascular Surgery|January 27, 2019
A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysisAnthony J Bleyer, Vincent A Scavo, Samuel E Wilson, et al.
Clinical Nephrology|November 19, 2010
Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisoneA J Bleyer, M Zivná, H Hulková, et al.
Pageof 67

Showing results (581-590 of 664) with videos related to

Sort By:
Pageof 67
Neuro-Oncology|April 18, 2001
Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption ConsortiumN D Doolittle, C P Anderson, W A Bleyer, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Life Science Alliance|January 22, 2022
Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for reninMark Sicking, Martina Živná, Pratiti Bhadra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Conduct of phase I trials in children with cancerM Smith, M Bernstein, W A Bleyer, et al.
Human Molecular Genetics|October 11, 2019
PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcomeAnna Pelet, Vaclava Skopova, Ulrike Steuerwald, et al.
Plos One|May 5, 2020
Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failureSebastian Clauss, Dominik Schüttler, Christina Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Journal of Virology|June 20, 2024
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate modelChristiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Vascular Surgery|January 27, 2019
A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysisAnthony J Bleyer, Vincent A Scavo, Samuel E Wilson, et al.
Clinical Nephrology|November 19, 2010
Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisoneA J Bleyer, M Zivná, H Hulková, et al.
Pageof 67